Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CRLNASDAQ:STAFNYSE:TRU On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCRLCharles River Laboratories International$137.60+1.0%$129.55$91.86▼$254.15$6.76B1.5994,089 shs494,377 shsSTAFStaffing 360 Solutions$1.62$1.62$1.08▼$5.69$2.66M0.721.31 million shsN/ATRUTransUnion$85.29-0.8%$81.65$66.38▼$113.17$16.64B1.671.71 million shs1.78 million shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCRLCharles River Laboratories International+0.95%+1.60%+17.26%-16.61%-34.92%STAFStaffing 360 Solutions0.00%0.00%0.00%0.00%-56.23%TRUTransUnion-1.00%+0.87%+3.39%-7.85%+16.01%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCRLCharles River Laboratories International4.4033 of 5 stars3.12.00.04.72.82.51.9STAFStaffing 360 SolutionsN/AN/AN/AN/AN/AN/AN/AN/ATRUTransUnion4.9477 of 5 stars4.35.01.74.43.50.81.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCRLCharles River Laboratories International 2.18Hold$171.8524.89% UpsideSTAFStaffing 360 Solutions 0.00N/AN/AN/ATRUTransUnion 2.57Moderate Buy$109.6928.62% UpsideCurrent Analyst Ratings BreakdownLatest CRL, TRU, TUNG, and STAF Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/23/2025CRLCharles River Laboratories InternationalRedburn AtlanticSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$188.00 ➝ $182.005/22/2025TRUTransUnionOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$96.00 ➝ $100.005/14/2025CRLCharles River Laboratories InternationalCowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy5/14/2025CRLCharles River Laboratories InternationalTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$179.005/8/2025CRLCharles River Laboratories InternationalBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$145.00 ➝ $155.005/8/2025CRLCharles River Laboratories InternationalRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$118.00 ➝ $140.005/8/2025CRLCharles River Laboratories InternationalEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeIn-Line ➝ Outperform$170.004/25/2025TRUTransUnionStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$120.00 ➝ $112.004/25/2025TRUTransUnionOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$93.00 ➝ $96.004/14/2025TRUTransUnionWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$130.00 ➝ $117.004/10/2025CRLCharles River Laboratories InternationalBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$160.00 ➝ $145.00(Data available from 5/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCRLCharles River Laboratories International$4.02B1.68$18.40 per share7.48$67.80 per share2.03STAFStaffing 360 Solutions$190.88M0.01N/AN/A($10.00) per share-0.16TRUTransUnion$4.26B3.91$5.62 per share15.17$22.14 per share3.85Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCRLCharles River Laboratories International$474.62M-$0.65917.3312.514.540.52%14.69%6.79%8/6/2025 (Estimated)STAFStaffing 360 Solutions-$26.04MN/A0.004.26N/A-13.25%N/A-37.63%6/11/2025 (Estimated)TRUTransUnion$284.30M$1.8858.4217.731.186.80%15.85%6.13%7/24/2025 (Estimated)Latest CRL, TRU, TUNG, and STAF EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/11/2025N/ASTAFStaffing 360 Solutions$0.13N/AN/AN/AN/AN/A5/7/2025Q1 2025CRLCharles River Laboratories International$2.06$2.34+$0.28$0.50$942.34 million$984.17 million4/24/2025Q1 2025TRUTransUnion$0.98$1.05+$0.07$0.75$1.07 billion$1.10 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCRLCharles River Laboratories InternationalN/AN/AN/AN/AN/ASTAFStaffing 360 SolutionsN/AN/AN/AN/AN/ATRUTransUnion$0.460.54%+5.27%24.47%1 YearsLatest CRL, TRU, TUNG, and STAF DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/8/2025TRUTransUnionquarterly$0.11500.54%5/22/20255/22/20256/6/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCRLCharles River Laboratories International0.651.411.14STAFStaffing 360 SolutionsN/A0.320.32TRUTransUnion1.181.701.70Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCRLCharles River Laboratories International98.91%STAFStaffing 360 Solutions15.19%TRUTransUnionN/AInsider OwnershipCompanyInsider OwnershipCRLCharles River Laboratories International1.30%STAFStaffing 360 Solutions7.93%TRUTransUnion0.25%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCRLCharles River Laboratories International21,40049.12 million50.47 millionOptionableSTAFStaffing 360 Solutions2001.64 million1.51 millionNot OptionableTRUTransUnion12,200195.10 million194.67 millionOptionableCRL, TRU, TUNG, and STAF HeadlinesRecent News About These CompaniesMackenzie Financial Corp Trims Stock Position in TransUnion (NYSE:TRU)May 29 at 5:05 AM | marketbeat.comTransUnion Report Reveals Q1 2025 Trends in Canadian Credit Market, Highlighting Growth Among New-to-Credit Consumers and Rising Delinquency RatesMay 28 at 6:13 AM | quiverquant.comCanadian Credit Market Reaches $2.5 Trillion in Outstanding Balances, with Gen Z Canadians Accounting for 10% of Credit GrowthMay 28 at 6:00 AM | globenewswire.comPublic Employees Retirement System of Ohio Boosts Stock Holdings in TransUnion (NYSE:TRU)May 28 at 5:06 AM | marketbeat.comTransUnion (NYSE:TRU) Receives $109.69 Consensus Target Price from BrokeragesMay 27 at 3:31 AM | americanbankingnews.comTransUnion (NYSE:TRU) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCMay 26, 2025 | marketbeat.comTransUnion (NYSE:TRU) Shares Sold by USS Investment Management LtdMay 26, 2025 | marketbeat.comTransUnion (NYSE:TRU) Given Consensus Rating of "Moderate Buy" by BrokeragesMay 26, 2025 | marketbeat.comSquarepoint Ops LLC Grows Stock Position in TransUnion (NYSE:TRU)May 25, 2025 | marketbeat.comMIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Increases Position in TransUnion (NYSE:TRU)May 25, 2025 | marketbeat.comOppenheimer Issues Positive Forecast for TransUnion (NYSE:TRU) Stock PriceMay 24, 2025 | marketbeat.comTransUnion Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)May 23, 2025 | benzinga.comQuantinno Capital Management LP Has $2.68 Million Stock Position in TransUnion (NYSE:TRU)May 23, 2025 | marketbeat.comTransUnion Analysis Uncovers Surprising Truth: Inflation-Adjusted Debt Growth Much Smaller Over the Last Five YearsMay 22, 2025 | globenewswire.comXn LP Has $176.87 Million Position in TransUnion (NYSE:TRU)May 22, 2025 | marketbeat.com4,976 Shares in TransUnion (NYSE:TRU) Purchased by Teza Capital Management LLCMay 22, 2025 | marketbeat.comTidal Investments LLC Purchases 92,234 Shares of TransUnion (NYSE:TRU)May 22, 2025 | marketbeat.comNuveen Asset Management LLC Increases Position in TransUnion (NYSE:TRU)May 22, 2025 | marketbeat.comWhy TransUnion (TRU) Crashed TodayMay 21, 2025 | insidermonkey.comWhy TransUnion (TRU) Crashed TodayMay 21, 2025 | msn.comCredit Score Stocks Slide as FHFA Head Questions PricingMay 21, 2025 | bloomberg.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesNVIDIA Stock Surges on Bullish News: How High Could It Climb?By Thomas Hughes | May 13, 2025View NVIDIA Stock Surges on Bullish News: How High Could It Climb?Nuclear Stocks Reach Critical Mass: The Time to Buy Is NowBy Thomas Hughes | May 27, 2025View Nuclear Stocks Reach Critical Mass: The Time to Buy Is NowApplied Digital's Strategic AI Play Gains MomentumBy Jeffrey Neal Johnson | May 21, 2025View Applied Digital's Strategic AI Play Gains MomentumTrump Orders Nuclear Overhaul: These 3 Stocks Stand to BenefitBy Dan Schmidt | May 28, 2025View Trump Orders Nuclear Overhaul: These 3 Stocks Stand to Benefit3 Huge S&P 500 Winners From Trump Trade Deal & The Biggest LoserBy Leo Miller | May 13, 2025View 3 Huge S&P 500 Winners From Trump Trade Deal & The Biggest LoserCRL, TRU, TUNG, and STAF Company DescriptionsCharles River Laboratories International NYSE:CRL$137.60 +1.35 (+0.99%) Closing price 05/29/2025 03:59 PM EasternExtended Trading$137.64 +0.03 (+0.03%) As of 05/29/2025 06:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.Staffing 360 Solutions NASDAQ:STAF$1.62 0.00 (0.00%) As of 02/20/2025Staffing 360 Solutions, Inc. engages in the provision of based staffing services and the acquisition and management of staffing companies in the information technology, financial, accounting, healthcare and cyber security industries. It operates through the following segments: Commercial Staffing, Professional Staffing-US and Professional Staffing-UK. The company was founded on December 22, 2009 and is headquartered in New York, NY.TransUnion NYSE:TRU$85.29 -0.67 (-0.78%) Closing price 05/29/2025 03:59 PM EasternExtended Trading$85.30 +0.01 (+0.02%) As of 05/29/2025 04:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.TransUnion operates as a global consumer credit reporting agency that provides risk and information solutions. The company operates through U.S. Markets, International, and Consumer Interactive segments. The U.S. Markets segment provides consumer reports, actionable insights, and analytic services to businesses, which uses its services to acquire new customers; assess consumer ability to pay for services; identify cross-selling opportunities; measure and manage debt portfolio risk; collect debt; verify consumer identities; and mitigate fraud risk. This segment serves various industry vertical markets, including financial services, technology, commerce and communications, insurance, media, services and collections, tenant and employment, and public sectors. The International segment offers credit reports, analytics, technology solutions, and other value-added risk management services; consumer services, which help consumers to manage their personal finances; consumer credit reporting, insurance and auto information solutions, and commercial credit information services. It serves customers in financial services, retail credit, insurance, automotive, collections, public sector, and communications industries through direct and indirect channels. The company was formerly known as TransUnion Holding Company, Inc. and changed its name to TransUnion in March 2015. TransUnion was founded in 1968 and is headquartered in Chicago, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Hormel Stock Near Lows, But Tariff Relief Could Boost Outlook Salesforce’s Stock Price Presents an Opportunity to Buy NVIDIA Will Set a New High Soon, Then Keep Rallying, Here’s Why Goodyear Stock Surges 28% in 2025: Is More Growth Ahead? Intel's Loss Is Broadcom's Gain as AVGO Dominates Networking Target's Big Bet: Is It a Cheap Stock or a Value Trap? Dividend Investors Looking for an Edge? 3 Stocks Insiders Bought Toyota Supercharges Joby: $250M Capital Infusion Ignites Stock Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
